AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin

"AIIMS, New Delhi is a site for COVAXIN Phase III clinical trial. This is a whole-virion inactivated vaccine co-sponsored by Indian Council of Medical Research (ICMR) and Bharat Biotech," AIIMS said in an advertisement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3nOEDkP
via IFTTT